Table 4.

Association of calculated threshold of main pancreatic duct (MPD) with malignancy in body-tail intraductal papillary mucinous neoplasms (IPMNs)

	Univariate analysis		Multivariate analysis
	OR	P value	OR	P value
MPD diameter (≥ 7.7 mm vs. < 7.7 mm)	4.93 (1.31–18.52)	0.018	9.83 (1.39–69.57)	0.022
Size (≥ 30 mm vs. < 30 mm)	4.97 (1.01–24.39)	0.048	3.65 (0.40–33.31)	0.25
CA19-9 (≥ 37 U/ml vs. < 37 U/ml)	14.17 (2.37–84.54)	0.004	28.69 (2.50–329.06)	0.007
Mural nodule (yes vs. no)	28.89 (3.01–277.02)	0.004	50.42 (2.79–912.89)	0.008
Diabetes Mellitus (yes vs. no)	1.17 (0.28–5.01)	0.83	2.21 (0.32–15.56)	0.42
CEA (≥ 5 vs. < 5 ng/ml)	0.72 (0.14–3.72)	0.69	0.32 (0.03–4.01)	0.38

CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, OR odds ratio